(Q33937533)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10843461%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

Methods for clinical monitoring of cyclosporin in transplant patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10843461%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10843461%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

R J Dumont

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10843461%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10843461%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10843461%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10843461%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10843461%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

427-447

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10843461%20AND%20SRC:MED&resulttype=core&format=json

Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by one-, two- and three-compartment models using Bayesian and non-linear least squares methods.

7 November 2019

cites work

1 reference

12 December 2020

Prediction of serum vancomycin concentrations using one-, two- and three-compartment models with implemented population pharmacokinetic parameters and with the Bayesian method.

1 reference

12 December 2020

A limited sampling strategy for the estimation of eight-hour neoral areas under the curve in renal transplantation.

1 reference

12 December 2020

Sensitivity and specificity of cyto-immunological monitoring in correlation with endomyocardial biopsies in heart transplant patients

1 reference

12 December 2020

Clinical utility of a Bayesian dosing program for phenytoin.

1 reference

12 December 2020

Estimated area-under-the-curve monitoring of Neoral in a stable pediatric renal transplant population: one-year experience

1 reference

12 December 2020

Neopterin as a new biochemical marker in the clinical monitoring of bone marrow transplant recipients

1 reference

12 December 2020

Monitoring of serum neopterin levels in renal transplant recipients: increased values during impaired renal function and cytomegalovirus infection

1 reference

12 December 2020

The relationship between cyclosporine pharmacokinetic parameters and subsequent acute rejection in renal transplant recipients

1 reference

12 December 2020

Bayesian pharmacokinetic/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluation

1 reference

12 December 2020

Computers in pharmacokinetics. Choosing software for clinical decision making

1 reference

12 December 2020

Cyclosporine plasma levels six hours after oral administration. A useful tool for monitoring therapy

1 reference

12 December 2020

Neopterin excretion after liver transplantation and its value in differential diagnosis of complications

1 reference

12 December 2020

Plasma interleukin 2 receptor levels in renal allograft recipients

1 reference

12 December 2020

Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring

1 reference

12 December 2020

Cytoimmunologic monitoring for the noninvasive diagnosis of cardiac rejection

1 reference

12 December 2020

Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients

1 reference

12 December 2020

Enumeration of transferrin-receptor-expressing lymphocytes as a potential marker for rejection in human cardiac transplant recipients

1 reference

12 December 2020

Pharmacokinetics and therapeutic drug monitoring of immunosuppressants

1 reference

12 December 2020

The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group

1 reference

12 December 2020

Prediction of acute graft rejection in renal transplantation: the utility of cyclosporine blood concentrations

1 reference

12 December 2020

Preliminary pharmacokinetic evaluation of a new galenical formulation of oral cyclosporine A: Neoral TM

1 reference

12 December 2020

Assessment of plasma neopterin in clinical kidney transplantation

1 reference

12 December 2020

Bayesian approaches in pharmacokinetic decision making.

1 reference

12 December 2020

The adverse impact of high cyclosporine. Clearance rates on the incidences of acute rejection and graft loss

1 reference

12 December 2020

Therapeutic drug monitoring of immunosuppressant drugs.

1 reference

12 December 2020

Cyclosporine-treated renal transplant patients have only partial inhibition of calcineurin phosphatase activity

1 reference

12 December 2020

Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients

1 reference

12 December 2020

Theophylline target concentration in severe airways obstruction - 10 or 20 mg/L? A randomised concentration-controlled trial

1 reference

12 December 2020

Noninvasive monitoring using serum amyloid A and serum neopterin in cardiac transplantation

1 reference

12 December 2020

Cyclosporine peak levels provide a better correlation with the area-under-the-curve than trough levels in liver transplant patients treated with neoral

1 reference

12 December 2020

Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy

1 reference

12 December 2020

Pharmacokinetic profile and variability of cyclosporine versus neoral in patients with cystic fibrosis after lung transplantation.

1 reference

12 December 2020

Interleukin 6 (IL-6) in serum and urine of renal transplant recipients

1 reference

12 December 2020

Usefulness of serum interleukin 2 receptor levels in renal allograft recipients

1 reference

12 December 2020

Immunologic monitoring of the cardiac transplant patient

1 reference

12 December 2020

A new microemulsion formulation of cyclosporin: pharmacokinetic and clinical features

1 reference

12 December 2020

Effect of the number of samples on Bayesian and non-linear least-squares individualization: a study of cyclosporin treatment of haematological patients with multidrug resistance.

1 reference

12 December 2020

Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporine

1 reference

12 December 2020

An updated comparison of drug dosing methods. Part III: Aminoglycoside antibiotics

1 reference

12 December 2020

Interleukin 2 levels and urine cytology distinguish between cyclosporine toxicity and rejection in renal and liver allograft recipients

1 reference

12 December 2020

Interleukin-2 receptor levels are increased in blood of heart transplant patients during infections

1 reference

12 December 2020

Comparative efficiencies of randomized concentration- and dose-controlled clinical trials.

1 reference

12 December 2020

Efficacy and side-effects of cyclosporine dose monitoring with levels 6 h after the morning dose in heart transplant patients

1 reference

12 December 2020

Expression of transferrin receptors on lymphocytes: its correlation with T-helper/T-suppressor cytotoxic ratio and rejection in heart transplant recipients

1 reference

12 December 2020

A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group

1 reference

12 December 2020

Abbreviated three-point kinetic profile in the 12-hour area under the curve for pharmacokinetic monitoring of cyclosporine

1 reference

12 December 2020

Target concentration strategy for cyclosporin monitoring

1 reference

12 December 2020

The use of therapeutic drug monitoring to optimise immunosuppressive therapy

1 reference

12 December 2020

Pharmacodynamic assays of the immunosuppressive action of cyclosporine therapy in transplant recipients

1 reference

12 December 2020

Natural killer-cell activity, interferon-alpha 2 production, and interleukin-2 production in cyclosporine-treated and conventionally immunosuppressed human allograft recipients

1 reference

12 December 2020

Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997).

1 reference

12 December 2020

Effect of simvastatin on cyclosporine unbound fraction and apparent blood clearance in heart transplant recipients

1 reference

12 December 2020

Abbreviated cyclosporine AUCs on Neoral--the search continues!

1 reference

12 December 2020

Forecasting individual pharmacokinetics

1 reference

12 December 2020

Area under the curve monitoring of cyclosporine therapy: the early posttransplant period.

1 reference

12 December 2020

Comparison of serum neopterin levels and urinary neopterin excretion in renal allograft recipients

1 reference

12 December 2020

Cyclosporine neoral monitoring and its correlation with the "area under the curve"

1 reference

12 December 2020

Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods.

1 reference

12 December 2020

Influence of in vivo immunosuppressive drugs on production of lymphokines

1 reference

12 December 2020

Calcineurin activity in children with renal transplants receiving cyclosporine

1 reference

12 December 2020

Prediction of cyclosporine area under the curve using a three-point sampling strategy after Neoral administration

1 reference

12 December 2020

Relationship of interferon-gamma and neopterin levels during stimulation with alloantigens in vivo and in vitro

1 reference

12 December 2020

Comparison of a Bayesian forecasting technique with a new method for estimating phenytoin dose requirements.

1 reference

12 December 2020

Challenges in cyclosporine therapy: the role of therapeutic monitoring by area under the curve monitoring.

1 reference

12 December 2020

Interleukin 2 production by peripheral blood lymphocytes in allograft recipients during acute rejection episodes

1 reference

12 December 2020

Target concentration intervention: beyond Y2K

1 reference

12 December 2020

Convenience of level of cyclosporine-Neoral at time 3 to determine the area under curve in renal transplant

1 reference

12 December 2020

Neoral conversion in stable thoracic transplant patients leads to dose reduction

1 reference

12 December 2020

Immunopharmacodynamic evaluation of cyclosporine-treated renal allograft recipients

1 reference

12 December 2020

Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by means of total, lean and different adipose factors dosing body weight using Bayesian and non-linear least squares methods.

1 reference

12 December 2020

Reevaluation of T cell subset monitoring in cyclosporine-treated renal allograft recipients.

1 reference

12 December 2020

An updated comparison of drug dosing methods. Part IV: Vancomycin

1 reference

12 December 2020

Some suggestions for measuring predictive performance

1 reference

12 December 2020

Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy. Technical note

1 reference

12 December 2020

Nonspecific increase of interleukin-2 receptor serum levels during immune events in heart transplantation

1 reference

12 December 2020

Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients

1 reference

12 December 2020

Immunologic monitoring of heart transplant patients under cyclosporine immunosuppression

1 reference

12 December 2020

Evaluation of a Bayesian approach to the pharmacokinetic interpretation of cyclosporin concentrations in renal allograft recipients.

1 reference

12 December 2020

Efficacy of area under the curve cyclosporine monitoring in renal transplantation

1 reference

12 December 2020

Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients

1 reference

12 December 2020

A limited sampling strategy for the measurement of cyclosporine AUC

1 reference

12 December 2020

Neopterin and interferon gamma serum levels in patients with heart and kidney transplants

1 reference

12 December 2020

Evidence that the soluble interleukin 2 receptor level may determine the optimal time for cystoscopically-directed biopsy in pancreaticoduodenal allograft recipients.

1 reference

12 December 2020

Interleukin-2 assay in serum and urine as a means of monitoring pancreatic allograft rejection

1 reference

12 December 2020

Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants

1 reference

12 December 2020

Abbreviated pharmacokinetic profiles in area-under-the-curve monitoring of cyclosporine therapy in de novo renal transplant patients treated with Sandimmune or Neoral. Neoral study group.

1 reference

12 December 2020

Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy.

1 reference

12 December 2020

A population pharmacokinetic model of cyclosporine in the early postoperative phase in patients with liver transplants, and its predictive performance with Bayesian fitting.

1 reference

12 December 2020

Cytoimmunologic monitoring and heart transplantation

1 reference

12 December 2020

Relationship of cyclosporine pharmacokinetic parameters to clinical events in human renal transplantation.

1 reference

12 December 2020

Effect of using warfarin plasma concentrations in Bayesian forecasting of prothrombin-time response

1 reference

12 December 2020

The randomized concentration-controlled trial: An evaluation of its sample size efficiency

1 reference

12 December 2020

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

1 reference

12 December 2020

Soluble interleukin-2 receptors in serum and bile of liver transplant recipients

1 reference

12 December 2020

Sequential determinations of urinary cytology and plasma and urinary lymphokines in the management of renal allograft recipients

1 reference

12 December 2020

Failure to predict cyclosporine area under the curve using a limited sampling strategy.

1 reference

12 December 2020

Relationship between cyclosporine bioavailability and clinical outcome in renal transplant recipients

1 reference

12 December 2020

Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral

1 reference

12 December 2020

Application of Bayesian forecasting to predict appropriate cyclosporine dosing regimens for renal allograft recipients

1 reference

12 December 2020

Cyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure.

1 reference

12 December 2020

Bayesian parameter estimation and population pharmacokinetics

1 reference

12 December 2020

Bayesian forecasting of serum lithium concentrations. Comparison with traditional methods

1 reference

12 December 2020

Do cyclosporin profiles provide useful information in the management of renal transplant recipients?

1 reference

12 December 2020

Comparison of neoral dose monitoring with cyclosporine through levels versus 2-hr postdose levels in stable liver transplant patients

1 reference

12 December 2020

An updated comparison of drug dosing methods. Part II: Theophylline

1 reference

12 December 2020

Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity

1 reference

12 December 2020

Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine A

1 reference

12 December 2020

A prospective study of the clinical utility of lymphocyte monitoring in the cardiac transplant recipient

1 reference

12 December 2020

Evaluation of a Bayesian regression program for predicting warfarin response.

1 reference

12 December 2020

Abbreviated area-under-the-curve strategy for monitoring cyclosporine microemulsion therapy in immediate posttransplant period

1 reference

12 December 2020

Bayesian estimation of cyclosporine clearance in bone marrow graft.

1 reference

12 December 2020

Update: clinically significant cytochrome P-450 drug interactions

1 reference

12 December 2020

The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion Group

1 reference

12 December 2020

Cyclosporine therapy for autoimmune disease.

1 reference

12 December 2020

Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients

1 reference

12 December 2020

Predicting patients' exposure to cyclosporin

1 reference

12 December 2020

Interleukin 2, interferon, and lymphotoxin in renal transplant recipients

1 reference

12 December 2020

Performance of Bayesian feedback to forecast lidocaine serum concentration: evaluation of the prediction error and the prediction interval.

1 reference

12 December 2020

Cytoimmunological monitoring in acute rejection and viral, bacterial or fungal infection following transplantation

1 reference

12 December 2020

Cell free serum interleukin-2 receptor levels after heart transplantation

1 reference

12 December 2020

Soluble interleukin-2 receptor level as an indicator of liver allograft rejection

1 reference

12 December 2020

Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation

1 reference

12 December 2020

Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes?

1 reference

12 December 2020